Invex Therapeutics Ltd (IXC.AX)
AUD 0.07
(-10.67%)
AUD 0.07
(-10.67%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.21 Million | 459.08 Thousand | 182.25 Thousand | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 1.21 Million | 459.08 Thousand | 182.25 Thousand | - | - | - |
| Operating Expenses | 3.34 Million | 8.97 Million | 4.24 Million | 2.44 Million | 3.4 Million | 232.25 Thousand |
| Selling, General and Administrative Expenses | 1.3 Million | 1.28 Million | 900.38 Thousand | 993.38 Thousand | 1.36 Million | 172.37 Thousand |
| Research and Development Expenses | 2.03 Million | 7.4 Million | 2.96 Million | 1.13 Million | 1.59 Million | 59.87 Thousand |
| Other Expenses | - | 432.34 Thousand | 208.65 Thousand | 310.08 Thousand | - | - |
| Cost and Expenses | 3.34 Million | -9 Million | -4.21 Million | -2.44 Million | 3.4 Million | 232.25 Thousand |
| Operating Income | -2.13 Million | -8.54 Million | -4.03 Million | -2.44 Million | -3.29 Million | -232.25 Thousand |
| Interest Expense | - | - | 79.88 Thousand | - | - | - |
| Income Tax Expense | -1.21 Million | -9.34 Million | -4.11 Million | -2.44 Million | -3.29 Million | -314.91 Thousand |
| Earnings before Tax | -2.85 Million | -7.74 Million | -3.95 Million | -2.28 Million | -3.36 Million | -232.12 Thousand |
| Net Income | -1.64 Million | -7.74 Million | -3.95 Million | -2.28 Million | -3.36 Million | -232.12 Thousand |
| Earnings Per Share Basic | -0.02 | -0.10 | -0.05 | -0.03 | -0.06 | -0.01 |
| Earnings Per Share Diluted | -0.02 | -0.10 | -0.05 | -0.03 | -0.06 | -0.01 |
| Weighted Average Shares Outstanding | 75.31 Million | 75.15 Million | 75.15 Million | 75.15 Million | 56.16 Million | 23.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.31 Million | 75.15 Million | 75.15 Million | 75.15 Million | 56.16 Million | 23.59 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | - | - | - |
| EBIT Margin | -0.59 | -19.56 | -23.27 | - | - | - |
| Profit Margin | -1.35 | -16.88 | -21.69 | - | - | - |
| EBITDA | -720.44 Thousand | - | - | - | - | - |
| Earnings Before Tax Margin | -1.76 | -18.62 | -22.13 | - | - | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.21 Million | - | 459.08 Thousand | 459.08 Thousand | 229.54 Thousand |
| Cost of Revenue | - | - | - | - | 300.41 Thousand | 150.2 Thousand |
| Gross Profit | - | 1.21 Million | - | 459.08 Thousand | 158.67 Thousand | 79.33 Thousand |
| Operating Expenses | 3.34 Million | 856.54 Thousand | 2.48 Million | 8.97 Million | 4.36 Million | 2.55 Million |
| Selling, General and Administrative Expenses | - | 575.66 Thousand | 731.43 Thousand | - | 562.4 Thousand | 431.4 Thousand |
| Research and Development Expenses | - | 280.87 Thousand | 1.75 Million | - | 3.8 Million | 1.9 Million |
| Other Expenses | - | - | - | 432.34 Thousand | - | - |
| Cost and Expenses | 3.34 Million | 856.54 Thousand | 2.48 Million | -9 Million | 4.36 Million | -2.4 Million |
| Operating Income | -3.34 Million | 355.71 Thousand | -2.48 Million | -8.54 Million | -4.36 Million | -1.95 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1.21 Million | -1.21 Million | 376.64 Thousand | -9.34 Million | -12.17 Thousand | 1112.00 |
| Earnings before Tax | -2.85 Million | 470.89 Thousand | -2.11 Million | -7.74 Million | -3.91 Million | -1.95 Million |
| Net Income | -1.64 Million | 470.89 Thousand | -2.11 Million | -7.74 Million | -3.9 Million | -1.95 Million |
| Earnings Per Share Basic | - | 0.01 | -0.03 | - | -0.05 | -0.03 |
| Earnings Per Share Diluted | - | 0.01 | -0.03 | - | -0.05 | -0.03 |
| Weighted Average Shares Outstanding | 75.15 Million | 75.45 Million | 75.15 Million | 75.15 Million | 75.15 Million | 75.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.15 Million | 75.43 Million | 75.15 Million | 75.15 Million | 75.15 Million | 75.14 Million |
| Gross Margin | - | 1.00 | - | 1.00 | 0.35 | 0.35 |
| EBIT Margin | - | -0.71 | - | - | -9.50 | 0.00 |
| Profit Margin | - | 0.39 | - | -16.88 | -8.50 | -8.50 |
| EBITDA | - | -856.54 Thousand | 376.64 Thousand | - | -4.36 Million | 1112.00 |
| Earnings Before Tax Margin | - | 0.29 | - | -18.62 | -9.50 | -8.50 |
1289
FUND
418550
IMCC
002907
MUX